Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Clinical trial NCT02999178 · COMPLETED

Trial details

NCT number: NCT02999178
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Diseases, Interstitial

Start date: 2017-01-17
Primary completion: 2019-04-23
Enrollment: 663

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.